MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop

MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.

  • Facebook
  • Twitter
  • Instagram
  • Pinteres

Facebook Twitter Instagram Pinterest
MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop
MedullaX MedullaX

What are You Looking for?

  • Clinical AI & Diagnostics
  • Digital Health & Interoperability
  • Government & Funding
  • NHS & Policy
  • Regulation & Safety
  • Research & Evidence
  • UK HealthTech & Deals
  • Workforce
Home Archives for Medullax Page 2

Medullax

80 posts
ByMedullax
February 2, 2026

Speech-based digital biomarkers: A new frontier for cognitive impairment assessment

  • Clinical AI & Diagnostics
ByMedullax
February 2, 2026

Applying Aviation Safety Principles to Clinical AI Collaboration

  • Clinical AI & Diagnostics
  • Regulation & Safety
ByMedullax
February 2, 2026

GLP-1 Medicines: New Government Guidance for Clinicians on Weight Loss and Diabetes

  • Government & Funding
ByMedullax
February 1, 2026

New initiative aims to boost rare cancer patient access to breakthrough trials

  • Government & Funding
ByMedullax
January 30, 2026

Mitigating Risks: Ensuring Patient Safety in Psychiatric Virtual Environments

  • Clinical AI & Diagnostics
  • Regulation & Safety
ByMedullax
January 30, 2026

Pancreatitis Risk: GLP-1 Agonist Warnings Strengthened Following Fatal Cases

  • Government & Funding
  • Research & Evidence
ByMedullax
January 30, 2026

UKRI Allocates £3M to Boost Diet and Health Innovation in UK Healthcare

  • Government & Funding
  • UK HealthTech & Deals
ByMedullax
January 30, 2026

Class 4 Medicines Defect: Viatris Arixtra Pre-filled Syringes Alert Issued

  • Government & Funding
ByMedullax
January 29, 2026

NHS to roll out enhanced bowel cancer screening for earlier detection

  • NHS & Policy
ByMedullax
January 29, 2026

Government Bill to Prioritise UK Medical Graduates for NHS Training

  • Government & Funding
MedullaX MedullaX
MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • AI Content Disclaimer
  • Editorial Policy
  • Corrections / Feedback Policy
  • Medical Disclaimer
Facebook Twitter Instagram Pinterest
©️ 2026 — MedullaX. All Rights Reserved.